142 related articles for article (PubMed ID: 7389973)
1. A case of centrolobular toxic necrosis of the liver due to aromatic retinoid--Tigason (Ro 10-9359).
Thune P; Mørk NJ
Dermatologica; 1980; 160(6):405-8. PubMed ID: 7389973
[TBL] [Abstract][Full Text] [Related]
2. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
Jagell S; Lidén S
Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
[TBL] [Abstract][Full Text] [Related]
4. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
Vahlquist A; Lööf L; Nordlinder H; Rollman O; Vahlquist C
Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699
[TBL] [Abstract][Full Text] [Related]
5. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma.
Tamayo L; Ruiz-Maldonado R
Dermatologica; 1980; 161(5):305-14. PubMed ID: 6449393
[TBL] [Abstract][Full Text] [Related]
6. Etretinate (Tigason) for skin disease.
Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967
[No Abstract] [Full Text] [Related]
7. Side effects due to RO 10-9359 (Tigason). A retrospective study.
Foged EK; Jacobsen FK
Dermatologica; 1982 Jun; 164(6):395-403. PubMed ID: 7117642
[TBL] [Abstract][Full Text] [Related]
8. Etretinate (Tigason) hepatitis in 2 patients.
van Voorst Vader PC; Houthoff HJ; Eggink HF; Gips CH
Dermatologica; 1984; 168(1):41-6. PubMed ID: 6698264
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses.
Viglioglia PA
Br J Dermatol; 1980 Nov; 103(5):483-7. PubMed ID: 7437314
[TBL] [Abstract][Full Text] [Related]
10. Severe disorders of keratinization: effects of treatment with Tigason (etretinate).
Marks R; Finlay AY; Holt PJ
Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177
[TBL] [Abstract][Full Text] [Related]
11. [The Netherton syndrome--a case report. Treatment with the aromatic retinoid RO-9359].
Albrecht-Nebe H; Reinicke C; Thormann T
Dermatol Monatsschr; 1982 Aug; 168(8):523-30. PubMed ID: 7173475
[No Abstract] [Full Text] [Related]
12. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis.
Glazer SD; Roenigk HH; Yokoo H; Sparberg M
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):683-7. PubMed ID: 7068976
[TBL] [Abstract][Full Text] [Related]
13. [Tolerability of an aromatic retinoid (RO 10 9359, etretinate, Tigason, Roche). Research on its toxicity on hematopoietic, renal and thyroid functions. Interactions with the metabolism of natural retinoids].
Fontan B; Bonafé JL; Moatti JP
Ann Dermatol Venereol; 1983; 110(1):23-31. PubMed ID: 6859752
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).
Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356
[TBL] [Abstract][Full Text] [Related]
15. [Oral treatment of lamellar ichthyosis (non-bullous congenital ichthyosiform erythroderma) with an aromatic retinoid (author's transl)].
Frenk E
Dermatologica; 1981; 162(2):91-103. PubMed ID: 7018943
[TBL] [Abstract][Full Text] [Related]
16. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
Gollnick H; Orfanos CE
Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
Pehamberger H; Esca SA; Holubar K
Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
[TBL] [Abstract][Full Text] [Related]
18. Retinoid hepatitis.
Sanchez MR; Ross B; Rotterdam H; Salik J; Brodie R; Freedberg IM
J Am Acad Dermatol; 1993 May; 28(5 Pt 2):853-8. PubMed ID: 8491880
[TBL] [Abstract][Full Text] [Related]
19. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
Findlay GH
S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876
[TBL] [Abstract][Full Text] [Related]
20. A rosacea-like eruption induced by Tigason (Ro 10-9359) treatment.
Crivellato E
Acta Derm Venereol; 1982; 62(5):450-2. PubMed ID: 6183905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
